Selected article for: "complement activation and cytokine storm"
Author: Santiesteban-Lores, Lazara Elena; Amamura, Thais Akemi; da Silva, Tiago Francisco; Midon, Leonardo Moura; Carneiro, Milena Carvalho; Isaac, Lourdes; Bavia, Lorena
Title: A double edged-sword - The Complement System during SARS-CoV-2 infection
  • Cord-id: h39iimei
  • Document date: 2021_5_1
    • ID: h39iimei
    Snippet: In the past 20 years, infections caused by coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 have posed a threat to public health since they may cause severe acute respiratory syndrome (SARS) in humans. The Complement System is activated during viral infection, being a central protagonist of innate and acquired immunity. Here, we report some interactions between these three coronaviruses and the Complement System, highlighting the central role of C3 with the severity of these infections. Although
    Document: In the past 20 years, infections caused by coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 have posed a threat to public health since they may cause severe acute respiratory syndrome (SARS) in humans. The Complement System is activated during viral infection, being a central protagonist of innate and acquired immunity. Here, we report some interactions between these three coronaviruses and the Complement System, highlighting the central role of C3 with the severity of these infections. Although it can be protective, its role during coronavirus infections seems to be contradictory. For example, during SARS-CoV-2 infection, Complement System can control the viral infection in asymptomatic or mild cases; however, it can also intensify local and systemic damage in some of severe COVID-19 patients, due to its potent proinflammatory effect. In this last condition, the activation of the Complement System also amplifies the cytokine storm and the pathogenicity of coronavirus infection. Experimental treatment with Complement inhibitors has been an enthusiastic field of intense investigation in search of a promising additional therapy in severe COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • accumulation prevent and acute respiratory syndrome: 1, 2, 3
    • activation inhibitor and acute aki kidney injury: 1
    • activation inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • activation inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • activation lymphocyte and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • activation lymphocyte and liver heart: 1
    • acute aki kidney injury and liver heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute ards respiratory distress syndrome and liver heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute respiratory syndrome and adhesion aggregation: 1, 2, 3, 4
    • acute respiratory syndrome and liver heart: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute tubular necrosis and liver heart: 1, 2